Journal article

Optimal approach for high-risk acute promyelocytic leukemia

Harry J Iland, John F Seymour, Andrew Wei

Current Opinion in Hematology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2014

DOI: 10.1097/MOH.0000000000000025

Citation metrics

8Web of Science
9Scopus

Keywords

Complete Remission
Receptor-Alpha
Anthracycline Monochemotherapy
Humans
Acute Promyelocytic Leukemia
Early Death Rate
Antineoplastic Combined Chemotherapy Protocols
Maintenance Chemotherapy
Hematology
Relapse
Arsenic Trioxide
Trans-Retinoic Acid
Induction Chemotherapy
Acute Myeloid-Leukemia
Risk-Adapted Therapy
Consolidation Chemotherapy
Additional Chromosome-Abnormalities
Leukemia, Promyelocytic, Acute
Risk Stratification
Treatment Failure
Science & Technology
Early Death
Life Sciences & Biomedicine
Elderly-Patients
Neoplasm Recurrence, Local
Risk Factors
Treatment Outcome
All-Trans Retinoic Acid
Flt3 Mutation Status